Hodgkin's lymphoma treatment cost in Republic of Korea typically starts with a consultation with a hematologist, which runs from $28 to $40. Primary treatment involving chemotherapy ranges from $1,100 to $2,400, depending on the staging and necessary drug protocols. Expenses are influenced by the choice of immunotherapy, radiotherapy sessions, and whether bone marrow transplantation is required. Patients can expect approximately 70-85% savings compared to the US, with top care centered in Seoul.
Typical Hodgkin's lymphoma Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases, patients should prioritize JCI-accredited facilities like Severance Hospital or SNUBH. These centers utilize digital BESTcare systems to coordinate multidisciplinary oncology protocols efficiently. Samsung Medical Center is ideal for those requiring presidential-standard care and state-of-the-art IGRT technology. Asan Medical Center offers the highest multidisciplinary volume, making it the best choice for patients needing complex organ-related support during intensive chemotherapy.
| Republic of Korea | Turkey | Austria | |
| Chemotherapy for breast cancer | from $2,200 | from $1,200 | from $15,000 |
| Chemotherapy | from $1,060 | from $3,000 | from $2,500 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
| Biological therapy | - | from $5,500 | from $20,000 |
| Immunotherapy with Keytruda (Pembolizumab) | - | from $3,300 | from $15,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Hodgkin's lymphoma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hodgkin's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hodgkin's lymphoma treatment journey.
Prof. Sung Hoon Noh is the Director of the Yonsei Cancer Center and specializes in advanced gastric cancer treatment. He has served in various leadership roles in various cancer and surgical societies and has been awarded multiple accolades for his outstanding work in surgery.
Prof. Keun Chil Park, MD is a hematologist-oncologist who graduated from Seoul National University College of Medicine. He specializes in lung, head and neck, and esophageal cancer and is a member of multiple professional organizations, including the Korean Medical Association, the Korean Association of Internal Medicine, the Korean Cancer Association, the American Society of Clinical Oncology, the American Association for Cancer Research, the European Society of Medical Oncology, the International Association for the Study of Lung Cancer, and the Korean Association for Clinical Oncology.